Manufacturing Readiness & Berry Amendment Compliance

The contract requires demonstration of scalable manufacturing capability to support limited-rate initial production and full-rate production, with strict adherence to U.S. sourcing mandates under the Berry Amendment for all critical components. This ensures that materials and parts essential to the end product are produced domestically, reinforcing supply chain integrity and national security objectives. The effort must be structured to validate production processes capable of meeting volume demands while maintaining quality and compliance throughout the manufacturing lifecycle. The subcontract is linked to the Department of Defense through the W6QK Acc-apg Natick office, with performance expected to occur in Stafford. The solicitation, posted on May 5, 2026, has a response deadline of May 19, 2026, and falls under NAICS code 339113, indicating a focus on medical equipment and supplies manufacturing. Compliance with Berry Amendment requirements is non-negotiable and must be fully documented and verifiable, as failure to meet U.S. sourcing standards will result in disqualification or contract non-compliance. All participants must prove their production scalability and domestic supply chain controls as part of the evaluation criteria.